A1CF | APOBEC1 complementation factor | | | | | | Tissue enhanced |
AADAT | Aminoadipate aminotransferase | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Tissue enhanced |
ACOX2 | Acyl-CoA oxidase 2, branched chain | Enzymes
| | | | | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
ALDH1L1 | Aldehyde dehydrogenase 1 family, member L1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C2 | Complement component 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CDO1 | Cysteine dioxygenase type 1 | Enzymes
| | | | | Tissue enhanced |
CFH | Complement factor H | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLDN1 | Claudin 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CTH | Cystathionase (cystathionine gamma-lyase) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
CYP4F11 | Cytochrome P450, family 4, subfamily F, polypeptide 11 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP4F3 | Cytochrome P450, family 4, subfamily F, polypeptide 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
FBP1 | Fructose-1,6-bisphosphatase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
FUOM | Fucose mutarotase | Enzymes
| | | | | Tissue enhanced |
GAS2 | Growth arrest-specific 2 | | | | | | Tissue enhanced |
GJB1 | Gap junction protein, beta 1, 32kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GPT | Glutamic-pyruvate transaminase (alanine aminotransferase) | Enzymes Plasma proteins
| | | | | Tissue enhanced |
GSTA1 | Glutathione S-transferase alpha 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
GSTA2 | Glutathione S-transferase alpha 2 | Enzymes
| | | | | Tissue enhanced |
HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
KYNU | Kynureninase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
LBX2 | Ladybird homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
MASP1 | Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
METTL7B | Methyltransferase like 7B | Predicted secreted proteins
| | | | | Tissue enhanced |
MIA2 | Melanoma inhibitory activity 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
OGDHL | Oxoglutarate dehydrogenase-like | Citric acid cycle related proteins Mitochondrial proteins
| | | | | Tissue enhanced |
PAH | Phenylalanine hydroxylase | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
PCK1 | Phosphoenolpyruvate carboxykinase 1 (soluble) | Citric acid cycle related proteins Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
PKLR | Pyruvate kinase, liver and RBC | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
PROS1 | Protein S (alpha) | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PSAT1 | Phosphoserine aminotransferase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
RBP5 | Retinol binding protein 5, cellular | Plasma proteins
| | | | | Tissue enhanced |
RP11-407N17.3 | CTAGE family member 5 isoform 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
SERPINA4 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SERPINA5 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
STEAP3 | STEAP family member 3, metalloreductase | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
SULT2A1 | Sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | Enzymes
| | | | | Tissue enhanced |
TSKU | Tsukushi, small leucine rich proteoglycan | Predicted secreted proteins
| | | | | Tissue enhanced |
UGT1A6 | UDP glucuronosyltransferase 1 family, polypeptide A6 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ZIC1 | Zic family member 1 | Transcription factors
| | | | | Tissue enhanced |